SKP2 and breast carcinoma: More recently, Li et al. [114], reported that treatment with SMIP004, an additional SKP2 inhibitor, led to an increased sensitivity to radiation in human breast cancer cell lines in vitro, with similar results obtained with breast cancer cell xenografts.